Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease Malcolm A. Leissring Leading Article 27 June 2016 Pages: 667 - 675
Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis Yong YangFangshuo ZhengXuefeng Wang Systematic Review 09 July 2016 Pages: 677 - 688
Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia Eduard ParelladaMiquel Bioque Review Article 02 June 2016 Pages: 689 - 701
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease Santiago Perez-LloretOlivier Rascol Review Article 25 June 2016 Pages: 703 - 717
Naltrexone: A Pan-Addiction Treatment? Elias AboujaoudeWael O. Salame Review Article 11 July 2016 Pages: 719 - 733
A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study Peter J. WeidenRaymond ManningMallery G. Mayo Original Research Article Open access 05 July 2016 Pages: 735 - 747
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension Wolfgang H. OertelYngve HallströmFor the RELOXYN Study Group Original Research Article Open access 11 July 2016 Pages: 749 - 760
Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy Sheridan M. Hoy Adis Drug Evaluation 08 August 2016 Pages: 761 - 772